Characterizing polymorphs in active pharmaceutical ingredients (APIs) is essential due to the wide variations of physicochemical properties shown between different crystal forms. The Agilent 8700 LDIR ...
From crystallographers' beards to billion-dollar lawsuits, the phenomenon of disappearing polymorphs has puzzled chemists for decades. Now researchers are finally unravelling the science behind why st ...
Gauging the adequate level and type of screening is the challenge when identifying relevant crystalline forms. Solid-dosage drugs remain the preferred dosage form due to ease of administration and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results